Phillip Scheinberg
Expertise in
7
conditions

Dr. Phillip Scheinberg

Hematology | Oncology
Office
Calais, ME 
22 Years of Experience
Expertise in
7
conditions
Office
Calais, ME 

Overview

Phillip Scheinberg is a Hematologist and an Oncologist practicing medicine in Calais, Maine. He has been practicing medicine for over 22 years.

Dr. Scheinberg is highly rated in 7 conditions, according to our data. His clinical expertise encompasses Aplastic Anemia, Anemia, Paroxysmal Nocturnal Hemoglobinuria (PNH), Paroxysmal Cold Hemoglobinuria, and Bone Marrow Transplant.

He is actively involved in clinical research, co-authoring 90 peer reviewed articles and participating in 2 clinical trials.

Specialties

Hematology
Oncology

Licenses

Internal Medicine in FL

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Cigna
  • EPO
  • HMO
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D

Locations

Office
Calais, ME 04619

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 1b/2 Open-Label, Dose Escalation & Expansion Study of Orally Administered Viracta (VRx)-3996 & Valganciclovir in Subjects With Epstein-Barr Virus-Associated Lymphoid Malignancies
A Phase 1b/2 Open-Label, Dose Escalation & Expansion Study of Orally Administered Viracta (VRx)-3996 & Valganciclovir in Subjects With Epstein-Barr Virus-Associated Lymphoid Malignancies
Enrollment Status: Completed
Publish Date: March 20, 2025
Intervention Type: Combination product
Study Drugs: VRx-3996, Valganciclovir
Study Phase: Phase 1/Phase 2
Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 and Increased Inflammatory Markers: a Phase III Randomized Clinical Trial (COVID-19 Coalition Brazil VI) (TOCIBRAS)
Safety and Efficacy of Tocilizumab in Moderate to Severe COVID-19 and Increased Inflammatory Markers: a Phase III Randomized Clinical Trial (COVID-19 Coalition Brazil VI) (TOCIBRAS)
Enrollment Status: Terminated
Publish Date: August 26, 2020
Intervention Type: Drug
Study Phase: Phase 3
View 1 Less Clinical Trial

90 Total Publications

Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatment.
Indirect treatment comparison of iptacopan versus pegcetacoplan for patients with paroxysmal nocturnal hemoglobinuria and residual anemia despite C5 inhibitor treatment.
Journal: Journal of comparative effectiveness research
Published: March 19, 2026

Frequently Asked Questions about Dr. Phillip Scheinberg

How do I make an appointment with Dr. Phillip Scheinberg?

You can book an appointment with Dr. Phillip Scheinberg by calling their office at 551-155-3695. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Phillip Scheinberg a top-rated expert for Aplastic Anemia?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Phillip Scheinberg is classified as an Elite expert for Aplastic Anemia, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Phillip Scheinberg specialize in?

While Dr. Phillip Scheinberg is a Hematology, they have specific expertise in Aplastic Anemia, Anemia, and Paroxysmal Nocturnal Hemoglobinuria (PNH). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Phillip Scheinberg participate in research or clinical trials?

Yes. Dr. Phillip Scheinberg has published 90 articles and abstracts on conditions like Aplastic Anemia. You can view a list of Dr. Phillip Scheinberg's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Phillip Scheinberg accept my insurance?

Dr. Phillip Scheinberg accepts most major insurance plans, including Cigna and Wellcare. We recommend calling the office directly at 551-155-3695 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Scheinberg's expertise for a condition
ConditionClose
View All 11 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile